Ganjapreneur.com

Medical Cannabis Bill Introduced In Alabama House

3/26/2019

A medical cannabis bill has been introduced in the Alabama House of Representatives by state Rep. Mike Ball (R-Huntsville).

HB 243 would extend Carly’s Law, which allowed a study at the University of Alabama Birmingham on using CBD-rich cannabis to treat children with intractable seizure disorders, for another two years, while clarifying a CBD-rich decriminalization bill known as Leni’s Law. The bill has twenty co-sponsors, including state Rep. John Rogers (D-Birmingham) and Republican Speaker of the House Mac McCutcheon.

Additionally, the bill would establish the Alabama Medical Cannabis Commission, which would be tasked with setting up a patient registry, issuing medical cannabis cards, and licensing the production, processing, and distribution of medical cannabis in Alabama. Patients would be required to be over nineteen and be suffering from one of a limited number of debilitating conditions to qualify for medical cannabis under the proposal.

“Carly’s law expires, and we need to extend that. There need to be clarifications on Leni’s Law. This is about helping sick people,” said state Rep. Mike Ball in an interview with AL.com. “The research is paying off. Some of the doctors want to do a medical card procedure. I’m doing one bill that will take care of that. We want to give doctors latitude on this.”

The study commissioned at UAB by Carly’s Law started dispensing cannabidiol oil to patients in 2015 and issued their findings in September 2018. The study which included 132 participants, 72 children, and 60 adults, found that CBD reduced the mean number of seizures from 144 every two weeks to 55 every two weeks — a “highly significant” reduction of two thirds, according to study authors.

End

House-Approved Idaho Hemp Bill Moves to Senate

3/26/2019

A bill to legalize hemp in Idaho unanimously passed the Senate State Affairs Committee on Monday, paving the way for it to be voted on by the full Senate, the Associated Press reports.

Gov. Brad Little indicated that if the measure passed the legislature he would sign it so long as it includes amendments sought by law enforcement officials.

The measure already passed the House. The Republican governor told the AP he was “a little chagrined” it passed the chamber without those amendments. The amendments would include language that would allow police to intercept illegal cannabis – containing more than .03 percent THC – without being stymied by the new hemp law.

Scott Bandy of the Idaho Prosecuting Attorneys Association indicated his group opposed the bill because, he says, it would prevent law enforcement officials from detaining potential criminals or using drug-sniffing dogs to locate illegal crops.

State Sen. Chuck Winder also said he was concerned about legalizing hemp while THC-rich cannabis remained outlawed.

This isn’t about an Ag issue out there, at least to me. This is about how do you provide a balance of allowing for potentially a crop that could be beneficial, without the disadvantage of the THC. So if there’s a balance that can be struck between the sponsors and law enforcement, I think that’s how we ought to go.” – Winder, via the Associated Press

His colleague Sen. Abbey Lee, who presented the bill to the committee, said lawmakers “really needed to do something this session” with regard to hemp legislation due to recent changes legalizing hemp at the federal level.

End

Canadian Government Proposes THC-Based Tax Rate for Edibles

3/25/2019

Canada’s Liberal government has included a THC-based tax rate for edibles and topical products in its 2019 budget, which are set to be allowed for sale in the state’s recreational market on or before Oct. 17, Investing News reports.

The plan is based on recommendations from the nation’s cannabis task force.

“Budget 2019 proposes that edible cannabis, cannabis extracts (including cannabis oils) and cannabis topicals be subject to excise duties imposed on cannabis licensees at a flat rate applied on the quantity of total tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis, contained in a final product.” – Canadian federal budget

Avtar Dhillon, president and executive chairman of Emerald Health Therapeutics, said the revised taxation structure could lead to reduced taxes on low-THC products and those derived from hemp.

“We expect that this proposed revision to the excise tax calculation will enhance our opportunity to utilize our purchased hemp in an economically viable way as feedstock for new cannabinoid-containing ingestible products.” — Dhillon, in a press release

The changes are expected to take place on May 1. The changes would not have an impact on the current taxes for flower, seeds, and seedlings sold in Canada.

End

Louisiana Officials: CBD Illegal Despite Federal Law Changes

3/25/2019

The Louisiana Office of Tobacco Control plans to issue citations to state retailers selling CBD products out of their shops, the agency announced on Friday. Juana Marine-Lombard, the commissioner for the office, says that — despite federal approval for products containing .03 percent THC under the Agriculture Act of 2018 — products containing even trace amounts of THC remain illegal under state law.

“…The Louisiana Board of Pharmacy has issued guidance its Guidance Document re Cannabidiol (CBD) Oil that any product extracted from a marijuana plant is classified as a schedule I under the Louisiana Controlled Dangerous Substance Law.” — Lombard, in a March 21 guidance document.

Lombard said the state Drug Policy Board is expected to issue an opinion and officials are awaiting an opinion from state Attorney General Jeff Landry “on the possible conflict between federal and state law.” The Tobacco Office guidance directs enforcement officials to order the removal of CBD products from shops; and while they will “continue to process pending CBD store applications,” they will not issue any permits until receiving guidance from the Drug Policy Board and Landry.

CBD-rich cannabis products were legalized for medical use in Louisiana in 2015. The Louisiana Board of Pharmacy guidance requires all cannabis products must comply with the legislature-approved medical cannabis law.

“Louisiana law does not make a distinction between CBD extracted from hemp and CBD extracted from marijuana,” the Nov. 2018 guidance says. “CBD is a compound of marijuana and therefore is considered marijuana under Louisiana law.”

The state does not have a program permitting hemp cultivation.

End

Cleveland School of Cannabis Triples Revenues

3/25/2019

Ohio’s Cleveland School of Cannabis more than tripled their revenue last year after operating with a deficit for its first 18 months, according to a Crain’s report. The school reported $1.125 million in revenues last year after logging $360,000 the year prior.

The school has graduated 111 and currently has 115 students enrolled in its programs with about 16 instructors and 10 full-time staff. Sixty-five percent of CSC graduates are currently employed or in paid, industry, internships, according to school tracking figures. The CSC partners with Ohio cannabis firms, including cultivators Buckeye Relief and Cresco Labs; and dispensaries Terrasana and The Botanist. It counts cannabis horticulture, dispensary training, and medical applications – along with an “executive” program combing the three – among its course offerings.

“Many of these students could be employed if they were willing to move, but they are waiting for licensees to open closer to their homes. More licensees are passing inspections every week, and we expect the demand for employees to grow rapidly.” – Cleveland School of Cannabis founder and CEO Austin Briggs, to Crain’s

Briggs said the school is planning to expand into Columbus with classes expected in the summer. Briggs indicated a plan to expand into two more states – possibly New Jersey and Florida – by 2021.

End

Legalization Pulled from New York Executive Budget

3/22/2019

Cannabis legalization will not be included in the upcoming state budget, but New York Gov. Andrew Cuomo is expecting lawmakers will come together on a deal in the summer, according to a CNN report.

“If we could get it done by the budget, that would be great,” Cuomo said. “But there’s a whole legislative session after the budget and my take is it will be done during the legislative session post budget and therefore I took the revenue out of the budget.”

Cuomo did not attribute the change to counties who have threatened to opt-out of the market, noting that those communities would not get a share of the cannabis-derived state revenues. The Democratic governor – whose party controls both legislative houses – said Assembly Speaker Carl Heastie “was quite clear” he thought it was better to do it outside of the budget.

“When it’s not done in the budget, then it is, in my opinion, harder to do as a standalone bill because it’s now just marijuana with a capital M. I said from day one that the marijuana issue was going to be controversial. There’s no doubt about that.” – Gov. Andrew Cuomo, in the interview

New York is bordered by cannabis legalization in Canada, Massachusetts, and Vermont; while New Jersey lawmakers are set to take up a legalization bill next week.

End

CVS Carrying CBD Topicals in Eight States

3/22/2019

CVS has started carrying CBD products in eight states, the company announced on Wednesday. The pharmacy chain will not carry CBD-containing supplements or food additives, opting instead for topicals.

According to a CNBC report, the products are available in Alabama, California, Colorado, Illinois, Indiana, Kentucky, Maryland and Tennessee.

“We have partnered with CBD product manufacturers that are complying with applicable laws and that meet CVS’s high standards for quality.” – CVS spokesperson, in a statement to CNBC

During an earnings conference call, Curaleaf CEO Joseph Lusardi said the company has been having “dialogue with national retailers for many months now” and they had reached a deal with CVS to sell its products at more than 800 stores.

CVS has not confirmed the partnership with Curaleaf; but stocks of the company jumped 17 percent on the Toronto Stock Exchange after the announcement. Curaleaf operates 40 dispensaries throughout the U.S.

Under the Farm Bill signed by President Donald Trump in December, hemp-derived CBD is legal but the Food and Drug Administration does not allow it to be added to food or beverages because it’s the active compound in the pharmaceutical Epidiolex.

Curaleaf indicated the products would be available on the CVS website.

End

Canadian Cannabis ETF Considers Adding U.S. Firms

3/22/2019

Horizons ETFs Management Canada Inc., which provides cannabis exchange-traded fund Horizons Life Sciences Index ETF, is hoping to add U.S. firms to its roster of publicly traded Canadian cannabis companies, according to a Bloomberg report.

CEO Steve Hawkins said the company, which holds C$1 billion in assets, is also considering a roster of U.S.-only cannabis companies. The Toronto Stock Exchange currently does not allow HMMJ to hold any companies with U.S. operations because they conflict with federal U.S. laws. The firm did add Colorado-based Charlotte’s Web Holdings Inc. earlier this week because their business is only hemp-derived products, which were legalized via the 2018 farm bill.

According to Bloomberg, the Horizon’s cannabis fund has returned over 60 percent so far this year – the best performing equity ETF in Canada. Hawkins said the U.S. ETF wouldn’t be traded on the TSX. Several cannabis companies with operations in the U.S. are listed on the Canadian Securities Exchange.

HMMJ is considering leveraged and inverse offerings for the U.S. ETF.

End

House Committee to Vote on Cannabis Banking Bill Next Week

3/21/2019

The House Financial Services Committee is set to vote on Tuesday on legislation to protect banks that work with the cannabis industry, according to a Marijuana Moment report.

The bi-partisan SAFE Banking Act, which carries 138 cosponsors, was discussed by the committee last month. The proposal calls on the Federal Financial Institutions Examination Council to issue “uniform guidance and examination procedures for depository institutions that provide financial services to cannabis-related legitimate businesses,” according to the report.

Rep. Maxine Waters, a California Democrat who chairs the Financial Services Committee, is one of the bill’s sponsors. The markup session is expected for 2:00 p.m. EST and will be live streamed. It will be the first Congressional cannabis vote of 2019.

In a statement, Aaron Smith, executive director of the National Cannabis Industry Association, noted the “unprecedented support” in the Democratic-led House.

“The fact that the SAFE Banking Act … is getting the serious consideration of a markup is a huge step in the right direction for the safety and transparency of the legal cannabis industry. We urge every member of Congress to support this legislation and help ease the unfair burdens facing cannabis businesses, their employees, regulators, and law enforcement due to current federal banking restrictions.” – Smith, in a press release

The measure would prevent federal regulators from punishing banks who work with cannabis-related businesses that are working within state laws. It would prevent them from limiting access to the Deposit Insurance Fund and protect ancillary businesses that work with cannabis businesses from being charged with money laundering and other financial crimes.

End

Vireo Health International Begins Trading on Canadian Securities Exchange

3/21/2019

American medical cannabis company Vireo Health International, Inc. has begun trading on the Canadian Securities Exchange under the ticker symbol “VREO,” the company announced Wednesday.

Vireo currently has operations in Minnesota, New York, Pennsylvania, Maryland, Rhode Island, and Ohio.

Dr. Kyle Kingsley, Vireo’s CEO, called the listing “an historic milestone” for the company.

“We believe that science will drive the lion’s share of long-term opportunity in the cannabis industry. From novel, efficient, scaled processing equipment, to proprietary consumer products and our expansive intellectual property portfolio, Vireo has positioned itself as the cannabis company of the future.” – Kingsley, in a statement

Previously, Vireo raised more than $50 million through a brokered and non-brokered private placement offering in combination with Darian Business Development Corp.

The listing is the first public cannabis listing of 2019, according to Vice President of Corporate Communications Albe Zakes.

Canadian stock markets have been a haven for some American companies who could not otherwise list for public trading.

End

4Blooms.Guru Announces APEX Branding Workshop for Cannabis, Hemp, and CBD Companies

3/20/2019

by Featured Announcement

San Diego, March 20, 2019 — 4Blooms.Guru, a national marketing agency for cannabis companies announces the APEX Branding Workshop which explores and crafts a cannabis, hemp or CBD brand. The problem they’ve observed is many companies are struggling to find their voice and can’t clearly articulate their mission, products, and services — visually or through words.

As a consequence, brands waste time and money executing weak marketing campaigns because the messaging isn’t built on a solid foundation of their origin story. This is where their APEX session intercedes and helps create the focal point for high-quality engagement, growth and success.

“An authentic voice can be the difference between a good brand and a great brand. Without a unique, recognizable branding approach, your products and services will get lost in the crowd, no matter how excellent they may be.” — Susan Rust, CEO, 4Blooms.Guru

A few of the most common branding and marketing issues clients have expressed include:

Don’t know their own brand story or how to communicate it
Don’t know their ideal target customers or want a different fan base
Spending money but ROI is weak
Site traffic is acceptable but conversions and sales are underperforming

The APEX Branding Workshop addresses these concerns and so much more.

What is 4Blooms.Guru’s APEX Branding Workshop?

4Blooms.Guru’s APEX Branding Workshop is a fully customized, proprietary half-day workshop created by national cannabis marketing company, 4Blooms.Guru. We’ll guide you through our tailor-crafted workshop to identify your origin story and purpose, to help you find and refine the message that resonates with your audience.

From this workshop, arrive at the truth: Why does your brand exist, and why should I care? You know yourself and your company best; what we do is help you identify the deep underlying reasons that inspired to create your company to begin with. Based on the outcome of the branding workshop, we’ll craft a campaign and articulate clearly why people should be a customer and advocate of your company.

How Does the APEX Branding Workshop Work?

Through the use of highly-targeted questions and our custom method for brainstorming, we lead you through an exciting process of self-discovery, reflection, and analysis. As you reach the end of the workshop, you’ll gain a more thorough understanding and expression of important points such as:

What is your company’s purpose?
What does your brand stand for?
What is your Origin Story?
Who are your ideal buyers?
Who is competing in your space?
What sets you apart?
What are the benefits of buying from you?

With that information, we create a custom brand architecture document that with the style guide becomes your company go-to reference book for content, imagery, voice and style for your content, media, print and packaging. Once all of the key brand architecture pieces are all in place and ready to go, we’re then in a much better place to craft a smart branding campaign just for you.

Crafted Campaign Concepts: Express Yourself

Using the workshop as a launching point, we’ll dive into a fully customized branding and marketing campaign that covers these crucial main points:

Campaign theme
Target audience: Where are they? What influences them?
Channel distribution (social media, YouTube, etc.)
Approach (every marketing campaign needs a clever angle)

It’s your Origin Story that shines through. The campaign is a vehicle for embodying and delivering your unique story, purpose, mission and values. You will remain the same — only more focused, amplified, and energized with new purpose and direction.

Who Can Benefit from the APEX Branding Workshop?

All companies can benefit from the APEX Branding Workshop. In particular, the workshop provides exceptional benefits for:

Newer brands — Companies uncertain of how to make an entry in the market
Rebranding — Those with an existing customer base, but slow/stalled growth
Expansion — Successful brands that want to expand or integrate vertically

Some companies who have recently launched are great examples of cohesive branding, web, packaging and print following their strong origin story:

LiveBlackRain.com
OKiWellness.com
RaywearCC.com
CannaPride.com

Work Directly with Cannabis Branding Professionals

We’ve seen firsthand how our APEX branding workshop can transform branding efforts from shy, timid presentations into powerful expressions of mission statements in ways that are creative, engaging, and impactful. This all becomes possible because, through the branding workshop, they rediscovered who they are, what they stand for, and what they can accomplish.

We’d love to work with your brand to develop your voice. You can only get this level of attention and inquiry at 4Blooms.Guru. Get in touch with us now to schedule your half-day APEX Branding Workshop.

Here’s a parting word from Susan Rust, CEO of 4Blooms.Guru, about the importance of creating your Origin Story:

“As humans, we’re wired to tell, hear and remember stories. It goes back to our pre-writing cultures. We want to know ‘who your people are’ and how that fits into our closest community of friends, family and beliefs. We look for that which resonates with our own selves. Through the Origin Story, we connect deeply with the customer to make them fans, someone who will repeat your story to others. Now that’s a win.”

About Susan Rust

With her deep knowledge and insight into the current legal cannabis bloom, Susan Rust is our resident guru at 4Blooms.Guru. Susan is also recognized nationally as a trainer, speaker, and mentor in the Drupal open-source community. Her expertise includes web project rescues and operations specialists who help companies scale through process, accountability and leadership training. Susan brings her extensive experience as leader of the 4Blooms.Guru agency. Her versatile team specializes in compliant cannabis packaging, branding, web, packaging and advertising for marijuana dispensaries, products, and services.

About 4Blooms.Guru

4Blooms.Guru was inspired by this unique ecosystem which needs a team that understands the marketplace and has the passion to serve you well. Let our talented team create exciting brands and creative campaigns for you. Let’s make your business bloom!

End

New Jersey Legislature Could Vote on Legalization Next Week

3/20/2019

Lawmakers in New Jersey will reportedly vote on an adult-use legalization measure as early as next week after it passed two state legislative committees on Tuesday, NJ.com reports. The Senate Judiciary Committee advanced the bill on a 6-4 vote with one abstention, while the Assembly Appropriations Committee advanced it on a 6-2 vote with two abstentions.

Gov. Phil Murphy included legalization in his campaign platform and, according to the report, “made dozens of calls” to whip votes. Both chambers must pass the bill before it reaches Murphy’s desk.

The measure would allow adults 21-and-older to possess one ounce of flower or five grams of concentrates and includes expungement language. During testimony to the Assembly Appropriations Committee, however, Newark Mayor Ras Baraka called the bill’s expungement process “cumbersome and not effective.”

“It still penalizes individuals that have been convicted of marijuana charges. We should remedy all situations, and give people an opportunity to live their lives wholly and peacefully so that previous cannabis offenses do not deny them access to job opportunities that can help improve their quality of life.” – Mayor Ras Baraka to NJ.com

If the bill passes, legal sales would begin about a year later. If it fails, lawmakers will likely wait until after the November election before taking up the issue again.

End

California Cannabis Firm Completes Renewable Energy Project

3/20/2019

Canndescent has completed its commercial-scale solar project in Desert Springs, California, the company announced on Monday. The 282.6-kilowatt system uses 734 solar modules to power the production facility. The Environmental Protection Agency and National Renewable Energy laboratory estimates the system offsets as much carbon as a 430-acre forest, reducing annual carbon emission by 365 metric tons.

The company points out that indoor cannabis growers consume an estimated 1 percent of the electricity in the United States and CEO Adrian Sedlin said it was “natural and appropriate for the cannabis industry and Canndescent to lead business community in addressing some of the world’s pressing challenges” as the industry “comes of age.”

The California Energy Commission requires all new nonresidential buildings to have rooftop solar by 2023.

Canndescent Chief Compliance Officer Tom DiGiovanni noted that the lack of access to traditional financial services delayed the project, which took eight weeks to construct.

“Given the restrictions around cannabis banking and lending and the complexities of energy projects and California civil construction in general, this was extraordinarily difficult to pull off. Nevertheless, we got it done and have established a template for the ‘green industry’ to go greener.” – Giovianni, in the release

The company plans to release an opensource whitepaper later this year sharing its solar project plans.

End

Illinois-Based Cannabis Company Raises $90M

3/20/2019

Grassroots Cannabis has completed its first capital raise of $90 million to expand its operations, the company announced on Tuesday. The company announced in December it was seeking $40 million in capital and ultimately increased the round to accommodate the subscriptions.

Grassroots indicated they plan to expand cultivation facilities in Illinois, Maryland, and Pennsylvania, build out its recently obtained dispensary licenses, and work with Vermont-based partners PhytoScience Management Group to expand its cultivation and testing lab facility and hemp-derived CBD business.

Brian Schinderle, the company’s executive vice president of finance, indicated Grassroots’ footprint is now in 11 states.

“We would like to thank the strong support we saw from both existing and new investors and look forward to continuing to earn their allegiance by both executing on our existing plans and looking to prudently continue to expand our platform.” – Schinderle, in a press release

The company has so far raised $165 million in equity and equity-linked securities to date. The recent round was led by Beacon Securities, Ltd., and Stoic Advisory, Inc.

Grassroots also operates in Michigan, Oklahoma, Ohio, North Dakota Arkansas, and Connecticut.

End

Florida Gov. Signs Bill Allowing Smokable Cannabis Products

3/19/2019

Florida medical cannabis patients are officially able to buy and consume smokable cannabis products after Republican Gov. Rick DeSantis signed legislation this week overturning the state’s controversial smoking ban, NBC reports.

Senate Bill 182 passed Florida’s Senate on March 7 in a 34-4 vote and was approved by the House on March 13 by a vote of 101-11. The ban was originally imposed by the state legislature in response to Florida’s 2016 landslide vote in favor of medical cannabis legalization, but faced immediate backlash and lawsuits from patient advocates. A judge ultimately ruled that the ban was unconstitutional, but the state — under the leadership of former governor Rick Scott (R) — appealed that decision.

Gov. DeSantis requested legislation overturning the ban shortly after taking office in January. He said that if lawmakers failed to act by Friday, he would take action himself by pulling the state out of the appeal lawsuit, which would have also lifted the ban.

“Over 70 percent of Florida voters approved medical marijuana in 2016. I thank my colleagues in the Legislature for working with me to ensure the will of the voters is upheld.” — Florida Gov. Ron DeSantis (R), in a press release

The shift is expected to open the market up to potentially tens of millions of dollars in additional revenue. The bill takes effect immediately, but Florida dispensaries probably won’t start selling smokable flower products until this summer.

End

Kentucky Hemp Product Sales Surged In 2018

3/19/2019

The Kentucky industrial hemp industry saw a lucrative 2018 as hemp product sales surged from $17 million in 2017 to $58 million in 2018 — a more than three-fold increase, according to a WAVE 3 report.

In addition to the explosive hemp product sales, hemp processors from around the nation are also purchasing more raw hemp from Kentucky farmers — $18 million worth just last year — according to a state Agriculture Department review of hemp processor reports. Much of the hype has been attributed to the rising national popularity of hemp-sourced CBD, which has become a popular infusion for edible and topical oils, lotions, dog treats, soaps, and other wellness products.

Dean Williams, an agronomy professor at the University of Kentucky, said that the crop is making a strong comeback particularly in Kentucky, where farmers used to grow the plant extensively.

“The cannabinoids are by far the largest sector in the [hemp] industry, making up 93% of the acreage and farmers in Kentucky.” — University of Kentucky Agronomy Professor Dean Williams, via WAVE 3

The December passage of the 2018 farm bill — which removed industrial hemp from the Controlled Substances Act — has also drummed up more excitement around the industry. Hemp farmers are reporting that it’s gotten easier to offload their product since then.

“We need to approach it with some level of caution only because we don’t have a good idea of what supply and demand will be,” said Williams.

End

New Mexico Lawmakers Approve Medical Cannabis & Decriminalization Bills

3/19/2019

New Mexico lawmakers have approved a series of bills aimed at reforming the state’s cannabis laws but failed to act on pending adult-use legalization legislation, reports Paul Armentano of NORML.

Senate Bill 323 is a decriminalization plan that would reduce first-time cannabis possession penalties for up to one-half ounce from a criminal misdemeanor carrying a potential 15-day jail sentence to a ‘penalty assessment,’ punishable by a $50 fine. Jail time will remain an option for repeat offenders or individuals carrying more than a half-ounce of cannabis. Once signed, the decriminalization law will take effect on July 1, 2019.

Senate Bill 406 is medical cannabis legislation that expands access to the plant and adds protection for patients. The bill updates the state’s medical cannabis rules to allow patients suffering from post-traumatic stress, severe chronic pain, Crohn’s disease, Lou Gehrig’s disease, sleep apnea, and neuropathy to access the program. The bill also prevents employers, social service workers, and hospitals from discriminating against patients because of their cannabis use and/or their failure to pass a drug test (because of their cannabis use). Lastly, the measure prevents lawmakers from capping the amount of THC or other cannabinoids present in commercial cannabis products.

Senate Bill 204, meanwhile, creates regulations for student patients who attend public schools, allowing for certain medical cannabis products to be stored and administered in school settings.

New Mexico Gov. Michelle Lujan Grisham (D) is supportive of the reforms and is expected to sign the bills into law. She also said that the adult-use issue will be broached again during next year’s 30-day legislative session.

End

Pura Vida Flower Review

3/18/2019

by Shango Los

Consumers everywhere scour the market for cannabis that is grown without synthetic nutrients and is just simply clean. So much of the cannabis in the commercial market is being grown with chemicals trying to make up for poor growing technique. That is why I was so glad to discover Pura Vida cannabis in Washington State. This family-owned operation is really passionate about clean cannabis with great taste.

Pura Vida is a woman- and minority-owned and operated company from the Chan family in Tacoma, Washington. They grow indoors under lights in the city but capture as much of the natural world as possible by using hand-made, natural inputs.

One of the challenges of mono-cropping indoors is that sterile environments create a perfect situation for pest infestations. Most indoor growers solve this challenge by spraying pesticides that you probably don’t want to be smoking, or by drowning their flowers in blends of essential oils that may end up influencing the taste of the flower. Not here — Pura Vida goes to the effort and expense of using beneficial insects to defend their garden from pests, meaning nothing suspicious is getting sprayed on your flowers.

Similarly, when some growers scale up, they choose nutrients that are less easily available to cannabis plants or that impart a synthetic taste to the final product because they are seen as easier to use in commercial-sized grows. The Chan family passes on these quick and dirty solutions, instead choosing all-natural ingredients like nutrient and compost teas, some of which they make themselves to their own family specifications. Using aerated teas and other brewed inputs can give the plants what they get in nature and create thriving plants with a healthy root zone and wide terpene profiles.

This heightened level of care for the rhizosphere really comes through in the flowers — which is the entire point, right?

Pura Vida grows three flagship strains that are sure to please. They also have a rotating series of other chemovars that come and go, so make sure you follow their social media to learn about those drops.

Pura Vida’s slogan is “Live your best life” and it comes through their flowers. For this review, the review team sampled their White Gorilla and Crystal Coma strains.

The Pura Vida “White Gorilla” is a cross of The White and GG #4. The batch we enjoyed tested at 26% with significant myrcene, caryophyllene, limonene, linalool, and humulene. That alone should tell you to expect a grand combination of gas, musk, and citrus.

The smell when opening the jar was roasted cashews, gas, floral notes, and roasted coffee. It was divine. A really unique profile we have not come across. It has the gas notes we love from Gorilla Glue with the addition of something extra that really makes it unique.

When we smoked it, we tasted acetone, cooked mushrooms, white chocolate, and white pepper. It totally captures the front of the tongue chemical gas tone of the Gorilla Glue lineage while incorporating the mushrooms and hash profile of The White. This is a great one to bring out to impress friends at a sesh because it has a remarkable smell and a great, heavy stone that leaves people feeling classically baked, with heavy eyes and smiles.

In contrast, the Crystal Coma certainly did not give any sort of couch lock or sedation. It is a euphoric strain full of energy, focus, creativity, and excitement. She is the 2014 Los Angeles High Times Best Sativa winner for good reason.

If you like snow on your flower, this one is for you. While the number of trichomes is certainly not proof of good flower alone, if you love frosty nugs, this will not disappoint. It has excellent “bag appeal.” Containing less humulene, it doesn’t hit you quite like the White Gorilla does when you open the jar, but don’t let that turn you off. When you break it up, the air fills with smells of lemon shortbread, yeasty sourdough bread, and lofi seductive florals with a slight ping of skunky alcohol esters. Delightful.

The flower was incredibly smooth both smoked and vaped. The terpenes didn’t hit with the same force as the White Gorilla; rather, a pinene and lemon taste sneaks up the back of your tongue as the high comes on.

Pura Vida is very involved in their local community, too. Once per month they have all hands out to work in the community. In the past, they have done outreach missions to the homeless, visited senior citizen homes, and done beach cleaning. I know of so many cannabis companies that pay community involvement lip-service but always seem to be too busy to actually help. I’ve seen Pura Vida actually follow through and regularly. It is good leadership for other cannabis growers.

Pura Vida is clean cannabis, with the beloved density and trichomes of indoor cannabis grown incredibly well, by a company with integrity. We expect Pura Vida may grow into a national brand but, for now, you can pick them up in Washington State.

Check their website at PuraVida-Cannabis.com for retailers and availability, and follow @PuraVidaCannabis on Instagram for regular updates!

End

Stoned-Driving Study Launching in Colorado; Subjects Wanted

3/18/2019

The Colorado School of Public Health is conducting a study on how cannabis affects the operation of motor vehicles, according to The Denver Channel.

The study will delve deeper into how being stoned affects one’s ability to drive. Right now, many states with legalization have stoned driving laws that specify an amount of THC that is allowed in the bloodstream. Colorado‘s limit, for example, is 5 nanograms of THC per milliliter of blood — the problem with that standard, however, is that it’s not a true reflection of intoxication.

“It’s not fair for the medicinal patients. Because cannabis stays in your system for about 30 days and if you use marijuana every day, the amount in your body is going to compound. You might not have used cannabis that day, but there is still cannabis in your system, so that could cause you to be positive on a test where you weren’t inebriated at all.” — Tyler Prock, via The Denver Channel

Researchers at the Colorado School of Public Health will follow subjects who are daily users or weekly users, as well as a control group of non-users. Subjects will take a driving test, consume cannabis, and then be tested again. After driving, further tests will be done using a VR headset and an iPad to assess eye-hand coordination and eye movement.

Ashley Brooks-Russell, an assistant professor at the Colorado School of Public Health said, “The goal is to better understand impaired driving so that we can prevent impaired driving.” Researchers hope to improve roadside sobriety tests with the research.

Subjects are still being sought; all individuals will be compensated for their participation.

End

Massachusetts Gov. Pushes for Harsher Cannabis DUI Rules

3/18/2019

Massachusetts Governor Charlie Baker has introduced a bill into the state legislature that would suspend the license of anyone who refuses a roadside drug test during a traffic stop — despite the lack of an accurate and effective test for cannabis impairment, MassLive reports.

Gov. Baker’s bill is seeking to make the penalty for refusing a drug test for cannabis the same as the penalty for refusing a breathalyzer test for alcohol. The problem with trying to equalize those standards is the lack of accurate testing methodologies for cannabis intoxication, unlike for alcohol.

“Drugged driving under the influence of marijuana is not new. What is new is our decision as a commonwealth to legalize, regulate and tax cannabis. In my opinion, that means that we have an enhanced obligation to address the issue of impairment anew as regulators, as industry, as participants in the criminal justice system and as policymakers.” — Cannabis Control Commissioner Britte McBride, via MassLive

The bill also includes provisions for expanded police training, changes to the state’s open container laws, and a public education program about the dangers of drugged driving that would cooperate with dispensaries across the state.

ACLU Field Director Matt Allen told reporters that it was too early for such legislation. “Our position is if a motorist faces legal penalties for refusing to take a test, that test should be based on evidence and science,” said Allen.

The bill is currently awaiting a hearing in the Massachusetts state legislature.

End

DNA Test to Predict Cannabis Effects Launched in Alberta Dispensaries

3/18/2019

A DNA test conducted in under an hour that claims to predict certain effects from cannabis that differ person to person has been launched in Alberta, Canada, The Vancouver Star reports.

The test is developed by Toronto company Lobo Genetics. Known as the Cube platform, the test uses oral swaps and then does a search of the DNA for certain markers identified by research to be associated with things like delayed onset, risk factors for mental illness, or whether the person is more likely to suffer memory loss. The test takes about an hour and costs $30.

“We’ve spoken to a lot of people that already thought there was something wrong with them – like they had taken cannabis before and they were the only one in their group where they had a strong reaction and then we test their genetics, and sure enough, they’re a slow metabolizer or they have one of the other [genetic] markers.” — John Lem, CEO of Lobo Genetics, via the Vancouver Star

Last week, Lobo Genetics set up five different stations at Nova Cannabis stores in Alberta, including two in Edmonton and one in each city of Calgary, Fort Saskatchewan, and Spruce Grove.

While an expert with the University of British Columbia was consulted about the development said that the technology is certainly based on science, he also said that most of the research has been on cells in a petri dish and not humans, which could be a limitation of the technology until more clinical research is completed.

The stations will remain in the Nova Cannabis stores for the rest of the month. As more brick and mortar cannabis stores are launched across Canada, Lobo Genetics hopes to expand their Cube stations to more provinces.

End

Florida Congress Votes to Eliminate Cannabis Smoking Ban

3/15/2019

The Florida House of Representatives has voted to approve legislation that would rescind the state’s ban on smoking medical cannabis. The state’s full Congress has now officially approved the measure, Forbes reports.

SB 182 passed the state House by a significant 101-11 margin in favor. The bill has already been approved by the Senate in a similarly wide margin of 34-4 in favor.

“I thank the Florida Legislature for taking action on medical marijuana and upholding the will of the voters.” — Gov. Ron DeSantis, on Twitter

SB 182 contains other changes to the medical cannabis program as well, such as tripling the previous limit of cannabis that doctors can order at one time — the new limit is now a six-month supply. This will reduce the number of doctor visits required by medical cannabis patients.

SB 182 also sets the standard that only minors with terminal illnesses will be able to smoke cannabis, among other small changes.

Gov. Ron DeSantis had tasked the legislature with getting a bill to rescind the smoking ban on his desk by March 15, which they have now successfully done. DeSantis is expected to sign the bill into law.

End

Cannabis Industry Employment Grew 44% in 2018 and Is Only Getting Started

3/15/2019

A report released by Leafly and Whitney Economics shows that the U.S. cannabis industry added more than 64,000 jobs in 2018, an employment growth rate of 44 percent.

Last year’s growth was more than double the industry’s progress in 2017, which saw a 21 percent increase in cannabis jobs.

The U.S. economy, according to federal statistics that exclude the cannabis industry, created 2.7 million new jobs as a whole in 2018.

The report analyzed cannabis sector employment data from a variety of sources, including economic formulas, state data, industry surveys, information from operators, and proprietary data. There is no official federal accounting of cannabis industry employment due to cannabis’ federal Schedule I designation.

The sector’s growth is notable in comparison to the recent decline in growth for jobs in the U.S. as a whole.

“Amid the roiling debate over American jobs, the legal cannabis industry remains a substantial and unrecognized engine of grassroots job creation. In 2019, America’s cannabis industry is one of the nation’s greatest economic success stories. That success deserves to be recognized and celebrated.” — Excerpt from the report

The total cannabis job count stated in the report was 211,000; that total raised to 296,000, however, when including ancillary cannabis industry jobs.

End

Get the daily briefing